Argenx Se ARGX
NASDAQ ARGX
$1,033.15 -20.31 (-1.93%)
At close: Sep 4, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Non Operating Income (2019 - 2021)

Argenx Se's (ARGX) quarterly Non Operating Income came in at -$420000.0 in Q1 2021, up 88.3% on a YoY basis from -$223043.5 in Q1 2020, and down 230.95% quarter-over-quarter from $320726.0 in Q4 2020.

Analysis

Argenx Se (ARGX) Non Operating Income (2019 - 2021) Analysis & Trends

Argenx Se (ARGX) has reported Non Operating Income for 3 consecutive years, with -$420000.0 the latest figure, recorded in Q1 2021.

  • For the quarter ending Q1 2021, Non Operating Income rose 88.3% year-over-year to -$420000.0; the trailing twelve-month figure through Mar 2021 stood at $168336.4 (changed N/A YoY), and the FY2021 full-year result was -$944000.0, up 37.11% from the prior year.
  • Non Operating Income retreated to -$420000.0 in Q1 2021 per ARGX's latest filing, from $320726.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $3.9 million in Q4 2019 and bottomed at -$3.6 million in Q1 2020.
  • Historically, Non Operating Income has averaged $42084.1 across 3 years, with a median of -$49637.0 in 2021.
  • The sharpest annual moves came in 2020 and 2021: Non Operating Income plunged 91.69% in 2020, then surged 88.3% in 2021.
  • Over 3 years, Non Operating Income stood at $3.9 million in 2019, then slumped by 91.69% to $320726.0 in 2020, then slumped by 230.95% to -$420000.0 in 2021.
  • According to Business Quant data, Non Operating Income over the past three periods registered -$420000.0, $320726.0, and -$3.6 million for Q1 2021, Q4 2020, and Q1 2020 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -73.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 387.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 234.30 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -53.64 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -420,000.00
Dec 31, 2020 320,725.97
Mar 31, 2020 -3.59 Mn
Dec 31, 2019 3.86 Mn